| Pharmacokinetics of Pegylated Liposomal Doxorubicin | 2003/01/01 | English | 1,108 |
| Pharmacokinetics and Pharmacodynamics of Cannabinoids | 2003/01/01 | English | 879 |
| Clinical Pharmacokinetics of Metformin | 2011/02/01 | English | 787 |
| Clinical Pharmacology of Tramadol | 2004/01/01 | English | 756 |
| Understanding the Dose-Effect Relationship | 1981/01/01 | English | 689 |
| Quantification of Lean Bodyweight | 2005/01/01 | English | 629 |
| Clinical Pharmacology of 5-Fluorouracil | 1989/04/01 | English | 621 |
| Sex Differences in Pharmacokinetics and Pharmacodynamics | 2009/01/01 | English | 621 |
| Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation | 2004/01/01 | English | 620 |
| Role of P-Glycoprotein in Pharmacokinetics | 2003/01/01 | English | 611 |
| Clinical Pharmacokinetics of Mycophenolate Mofetil | 1998/01/01 | English | 609 |
| Pegylation | 2001/01/01 | English | 599 |
| Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition | 2000/01/01 | English | 593 |
| Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism | 2002/01/01 | English | 568 |
| Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections | 2004/01/01 | English | 557 |
| Clinical Pharmacokinetics of Tacrolimus | 1995/12/01 | English | 556 |
| Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine | 2017/01/19 | English | 554 |
| Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate | 2010/04/01 | English | 548 |
| Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids | 2005/01/01 | English | 541 |
| Inhibition and Induction of Cytochrome P450 and the Clinical Implications | 1998/01/01 | English | 537 |
| Pharmacokinetic Interactions with Rifampicin | 2003/01/01 | English | 504 |
| Effect of Obesity on the Pharmacokinetics of Drugs in Humans | 2010/02/01 | English | 502 |
| Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies | 2010/08/01 | English | 485 |
| Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions | 1997/03/01 | English | 482 |
| Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate | 2008/01/01 | English | 469 |
| Pregnancy-Induced Changes in Pharmacokinetics | 2005/01/01 | English | 446 |
| Clinical Pharmacokinetics of Imatinib | 2005/01/01 | English | 439 |
| Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance | 2009/11/01 | English | 436 |
| Drug Interactions with Tobacco Smoking | 1999/01/01 | English | 434 |
| Enterohepatic Circulation | 2002/01/01 | English | 429 |